Amicus Therapeutics Inc (FOLD)
10.10
-0.28
(-2.70%)
USD |
NASDAQ |
Nov 14, 16:00
10.10
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Gross Profit (Annual): 362.03M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 362.03M |
| December 31, 2022 | 290.63M |
| December 31, 2021 | 271.05M |
| December 31, 2020 | 229.84M |
| December 31, 2019 | 160.27M |
| December 31, 2018 | 76.84M |
| December 31, 2017 | 30.69M |
| December 31, 2016 | 4.125M |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 1.224M |
| December 31, 2013 |
| Date | Value |
|---|---|
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | |
| December 31, 2009 | 64.36M |
| December 31, 2008 | 14.97M |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
160.27M
Minimum
2019
362.03M
Maximum
2023
262.77M
Average
271.05M
Median
2021
Gross Profit (Annual) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 3.027M |
| Alnylam Pharmaceuticals Inc | 1.518B |
| Ionis Pharmaceuticals Inc | 778.51M |
| Arbutus Biopharma Corp | -- |
| Krystal Biotech Inc | 47.60M |